ALDH1A1 and breast carcinoma: The silencing of the ALDH1A1 gene in human breast cancer cells increases their sensitivity to paclitaxel with a concomitant increase of ROS formation, and similar results were obtained with doxorubicin, sorafenib, and staurosporine[13].